Will AbbVie back off Humira advertising now that it’s announced it will buy Allergan? Maybe. But for now, the Illinois drugmaker is showing no signs of slowing its long-running robust TV ad push for ...

The fall magazines are always fat with ads, and the latest issues of People were no exception. I was happy to spot many DTC ads in one very hefty issue, two of which really stood out—one for Pfizer’s ...

More than one-fourth of all top-10 pharma TV spending in July came from one brand—AbbVie's Humira. The immunology blockbuster brand dropped $42.5 million on TV ads, well ahead of Gilead Sciences’ ...

WASHINGTON (Reuters) - An advertisement for Abbott Laboratories' Humira minimizes the arthritis drug's risks while suggesting it can treat a wider range of patients than it is approved to treat, the U ...

The second in a pair of complementary spots for AbbVie’s immunology drug Humira recently hit airwaves, and while it shed some light on the mysterious ad that preceded it, the sequence has elicited a ...

Image above from a recent Humira ad. The Humira wars have begun, as the first branded biosimilar to break Abbvie’s 20-year exclusivity on the top-selling anti-inflammatory drug has launched, cutting ...